Health
Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis – News-Medical.Net
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure…
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease. The positive results validate Owlstone Medical’s EVOC® probe strategy for the development of breath-based diagnostic and prognostic tests for Nonalcoholic Fatty Liver Disease (NAFLD) and associated N…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
General24 hours agoReserve Bank board still looking for yesterday’s news
-
Business23 hours agoASX ETFs to target amidst an ageing population